Importantly, priming with RANKL resulted in developing precursor sensitivity to soluble factors produced by prostate cancer cells, evident in a significant increase in numbers of large multinucleated osteoclasts in PC3 and LNCaP CM-treated cultures (Figure 2C-F). The gene discussed is TNFSF11; the disease is prostate cancer.